Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Friday, December 31, 2021.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
Limited quarterly history available
ROE needs at least three reported quarters before a meaningful chart is shown.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$50.27M
Return on Equity (ROE)
-708.48%
TTM Avg
156.13%
3Y Avg
510.26%
5Y Avg
342.91%
Market Cap
$49.71M
Return on Equity (ROE)
-90.44%
TTM Avg
-163.19%
3Y Avg
-112.62%
5Y Avg
-86.58%
Market Cap
$49.45M
Return on Equity (ROE)
N/A
TTM Avg
296.81%
3Y Avg
-175.08%
5Y Avg
-1071.79%
Market Cap
$51.12M
Return on Equity (ROE)
-52.72%
TTM Avg
-32.48%
3Y Avg
-92.81%
5Y Avg
-85.98%
Market Cap
$51.19M
Return on Equity (ROE)
-57.10%
TTM Avg
-36.66%
3Y Avg
-227.16%
5Y Avg
-314.45%
Market Cap
$51.23M
Return on Equity (ROE)
-278.89%
TTM Avg
-162.92%
3Y Avg
25.71%
5Y Avg
0.37%
Market Cap
$49.25M
Return on Equity (ROE)
-17.84%
TTM Avg
-32.49%
3Y Avg
-23.88%
5Y Avg
-18.14%
Market Cap
$48.89M
Return on Equity (ROE)
-42.01%
TTM Avg
-2.07%
3Y Avg
11.82%
5Y Avg
5.22%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| biote Corp. (BTMD) | $50.28M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -708.48% | 156.13% | 510.26% | 342.91% |
| INmune Bio, Inc. (INMB)vs › | $49.71M | -90.44% | -163.19% | -112.62% | -86.58% |
| Clene Inc. (CLNN)vs › | $49.45M | N/A | 296.81% | -175.08% | -1071.79% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -52.72% | -32.48% | -92.81% | -85.98% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | -57.10% | -36.66% | -227.16% | -314.45% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -278.89% | -162.92% | 25.71% | 0.37% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -17.84% | -32.49% | -23.88% | -18.14% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | -42.01% | -2.07% | 11.82% | 5.22% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A | -374.04% | -326.22% | -254.86% |
ROE
N/A
ROA
5.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2021-12-31 | 790.76% |
